Toll-like Receptors and their Adaptors in Innate Immunity

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 1, 2005-02 ,pp. : 3-11

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet Toll-Like Receptor Expression: The Link Between “Danger” Ligands and Inflammation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 5, 2010-12 ,pp. : 322-333

Bentham Science Publishers

Access to resources Recommend Favorite

Negative Regulators of Toll-like Receptor 4-Mediated Macrophage Inflammatory Response

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4143-4153

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Toll-Like Receptors and Innate Immunity: Potential Drug Targets for Treatment of Infectious, Inflammatory, and Autoimmune Diseases (Executive Editor: Emilio Jirillo)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4089-4090

Bentham Science Publishers

Access to resources Recommend Favorite

Oxymatrine inhibits lipopolysaccharide-induced inflammation by down-regulating Toll-like receptor 4/nuclear factor-kappa B in macrophages

By Zhang Yu   Yan Ruhong   Hu Yae  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 4, 2015-01 ,pp. : 253-260

NRC Research Press

Access to resources Recommend Favorite